BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29949418)

  • 1. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis.
    Ng CS; Altinmakas E; Wei W; Ghosh P; Li X; Grubbs EG; Perrier ND; Lee JE; Prieto VG; Hobbs BP
    AJR Am J Roentgenol; 2018 Aug; 211(2):W109-W115. PubMed ID: 29949418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models.
    Ng CS; Wei W; Altinmakas E; Li X; Ghosh P; Perrier NA; Grubbs E; Prieto VG; Lee JE; Hobbs BP
    AJR Am J Roentgenol; 2018 Apr; 210(4):W156-W163. PubMed ID: 29412015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance.
    Ng CS; Altinmakas E; Wei W; Ghosh P; Li X; Grubbs EG; Perrier NA; Prieto VG; Lee JE; Hobbs BP
    Acad Radiol; 2018 Jul; 25(7):861-868. PubMed ID: 29398440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
    Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
    AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
    Boland GW; Blake MA; Holalkere NS; Hahn PF
    AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma.
    Altinmakas E; Perrier ND; Grubbs EG; Lee JE; Prieto VG; Ng CS
    Acta Radiol; 2020 Aug; 61(8):1080-1086. PubMed ID: 31791129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental adrenal lesions detected on enhanced abdominal dual-energy CT: can the diagnostic workup be shortened by the implementation of virtual unenhanced images?
    Botsikas D; Triponez F; Boudabbous S; Hansen C; Becker CD; Montet X
    Eur J Radiol; 2014 Oct; 83(10):1746-51. PubMed ID: 25064663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features.
    Park BK; Kim CK; Kwon GY; Kim JH
    Eur Radiol; 2007 Nov; 17(11):2804-9. PubMed ID: 17549484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
    Patel J; Davenport MS; Cohan RH; Caoili EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
    Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
    Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
    Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
    AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
    Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
    Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.